| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Biophys J, February 2002, p. 676-683, Vol. 82, No. 2
Laboratory of Molecular Biophysics, Department of Biochemistry, The University of Oxford, Oxford OX1 3QU, United Kingdom
| |
ABSTRACT |
|---|
|
|
|---|
Ionotropic glutamate receptors are essential for fast
synaptic nerve transmission. Recent x-ray structures for the
ligand-binding (S1S2) region of the GluR2
-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid
(AMPA)-sensitive receptor have suggested how differences in
protein/ligand interactions may determine whether a ligand will behave
as a full agonist. We have used multiple molecular dynamics simulations
of 2-5 ns duration to explore the structural dynamics of GluR2 S1S2 in
the presence and absence of glutamate and in a complex with kainate.
Our studies indicate that not only is the degree of domain closure
dependent upon interactions with the ligand, but also that
protein/ligand interactions influence the motion of the S2 domain with
respect to S1. Differences in domain mobility between the three states
(apo-S1S2, glutamate-bound, and kainate-bound) are surprisingly
clear-cut. We discuss how these changes in dynamics may provide an
explanation relating the mechanism of transmission of the
agonist-binding event to channel opening. We also show here how the
glutamate may adopt an alternative mode of binding not seen in the
x-ray structure, which involves a key threonine (T480) side chain
flipping into a new conformation. This new conformation results in an
altered pattern of hydrogen bonding at the agonist-binding site.
| |
INTRODUCTION |
|---|
|
|
|---|
Fast synaptic transmission between nerve cells in
mammals is carried out predominantly by ionotropic glutamate receptors
(iGluR). These receptors are a family of ligand-gated ion channels that open in response to the binding of glutamate (Dingledine et al., 1999
;
Sprengel et al., 2001
). Glutamate is released presynaptically and binds
to a post-synaptic receptor gating a cation-selective channel, thus
depolarizing the post-synaptic cell. Although glutamate is the natural
ligand, the various iGluRs identified by sequence comparisons may also
be classified in terms of their agonist pharmacology (Hollmann and
Heinemann, 1994
). Those receptors (GluR1-4) that show greatest
sensitivity to the synthetic agonist
-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) are
termed AMPA receptors (Borges and Dingledine, 1998
). Likewise, those
that show greatest sensitivity to kainate (GluR5-7 and KA1-2) are
referred to as kainate receptors (Lerma et al., 1997
; Chittajallu et
al., 1999
). Receptors activated by the synthetic
N-methyl-D-aspartate (NMDAR1 and
NMDAR2a-d) are called NMDA receptors (Yamakura and Shimoji, 1999
) and
need glycine and glutamate as the natural agonist. In all of these
GluRs the agonist/antagonist binding site is located within the
extracellular (EC) region of the protein (Fig.
1). Preceding the glutamate-binding domains is an amino-terminal domain (ATD). This has ~16% sequence identity to the bacterial leucine/isoleucine/valine-binding protein (O'Hara et al., 1993
). Although the ATD is not directly involved in
ligand binding, it has been shown to be important for subtype-specific interactions (Leuschner and Hoch, 1999
). The polypeptide chain then
proceeds to make up most of domain S1 of the ligand-binding site before
forming two transmembrane (TM) helices (M1 and M2) and an intervening
P-loop, suggestive of an inverted potassium channel TM architecture
(Panchenko et al., 2001
). As it leaves M2 the polypeptide chain then
forms most of domain S2 in the ligand-binding cleft before forming a
third TM helix, M3, followed by a short C-terminus. The x-ray
structure of a water-soluble construct corresponding to the
ligand-binding domains (S1S2) of the EC region of GluR2 was first
solved by Armstrong et al. (1998)
, revealing the agonist-binding site
to lie at the interface between S1 and S2.
|
Evidence from single-channel recordings on homomeric GluR4(i) receptors
showed that currents elicited by kainate as the agonist were up to
eightfold smaller than those elicited by AMPA or glutamate (Smith et
al., 2000
). Hence, kainate may be thought of as a partial agonist of
the AMPA receptor. Recently, a series of high-resolution crystal
structures of different agonists and of an antagonist (DNQX) bound to
the GluR2 ligand-binding domain was published (Armstrong and Gouaux,
2000
). Comparison of these structures of the AMPA- and glutamate-bound
complexes revealed a domain closure of ~20° relative to the apo
state. In contrast, the partial agonist kainate induced a domain
closure of only ~12° .
Although it is evident that inter-domain movement occurs upon ligand binding, x-ray structures provide only static snapshots of a dynamic process. In this paper we use molecular dynamics (MD) simulations to explore changes in the conformational dynamics of the GluR2 ligand-binding construct in response to different patterns of binding-site occupancy, i.e., no ligand versus full agonist (glutamate) versus partial agonist (kainate). These simulations provide an insight into agonist dependency of the dynamics of the ligand-binding construct on a multi-nanosecond timescale.
| |
METHODS |
|---|
|
|
|---|
Crystal structures (Armstrong and Gouaux, 2000
) for the
glutamate (1FTJ), kainate (1FWO), and the apo (1FTO) states of the S1S2
construct were downloaded from www.rcsb.org. The 1FTJ coordinate set of
the glutamate-bound state was used to generate an additional apo state
(hereafter referred to as Apo2) from which the glutamate was removed
and the binding site solvated with five additional water molecules
(Table 1). We use the same residue
numbering as that employed by Armstrong and Gouaux (2000)
for ease of
comparison. Missing residues were added using the molecular editor in
Quanta (Accelrys, San Diego, CA) and the N- and C-termini were
acetylated and amidated, respectively, to mimic the continuation of the
protein chain. Before MD simulations were started, we performed
pKA calculations (Adcock et al., 1998
) to
determine whether any of the binding-site residues were likely to adopt
nonstandard ionization states. On the basis of the results of these
calculations, all residues were modeled in their default ionization
states.
|
Crystallographic waters within 4 Å of the protein were retained. Each
of the three starting structures (glutamate-bound, kainate-bound, and
apo) were solvated by a box of ~11,000 simple point charge (SPC) (Hermans et al., 1984
) water molecules (Table 1) and the appropriate number of counterions were added to ensure overall neutrality of the system. The protein and ligands were then subjected to a restrained run of 200 ps, whereby the protein (and ligand if
present) were harmonically restrained with a force of 1000 kJ
mol
1. After this period all restraints were
removed and the simulations run for 2 ns. For simulation of Apo2 this
was extended to 5 ns. Electrostatics were calculated using particle
mesh Ewald (PME) (Darden et al., 1993
; Essman et al., 1995
) with a
10-Å cutoff. The temperature was coupled with the Berendsen thermostat
(Berendsen et al., 1984
), at 300 K with
T = 0.1 ps. The time step for integration was 2 fs, and coordinates and
velocities were saved every 5 ps. The LINCS (Hess et al., 1997
)
algorithm was used to restrain bond lengths. All simulations were
performed using GROMACS (http://rugmd0.chem.rug.nl/~gmx/index.html) (Berendsen et al., 1995
) running on a Silicon Graphics Origin 2000 computer.
| |
RESULTS |
|---|
|
|
|---|
Domain closure and inter-domain motions
Comparison of the crystal structures of the S1S2 construct with
and without agonists (Armstrong and Gouaux, 2000
) suggested that the
degree of domain closure between the two domains could be responsible
for differences in the effectiveness of ligands as agonists. In our MD
simulations we wanted to explore this aspect further in terms of the
intra- and inter-domain motion and of how the motion of the domains is
influenced by the ligand.
The drift of each simulated structure from its initial crystallographic
conformation provides information on the quality of the simulations.
The drift was measured in terms of the root mean square deviation
(RMSD) of the C
atoms from the initial structures as a function of
time. For the three (Apo1, Glu1, and Kai) simulations after an initial
rise (during the first ~300 ps) the C
RMSD plateaus at ~1.25 Å (data not shown). This is indicative of a stable simulation. To obtain
an initial estimate of the relative motions of the two domains during
the 2 ns, we determined the C
RMSD of the second domain (S2) after
fitting the S1 domain C
atoms to the initial structure(s) (Fig.
2 A). In this case the domain
S2 C
RMSDs for the Glu1 and Kai simulations plateau at ~1.5 Å after 300 ps. In contrast, the Apo1 simulation shows a C
RMSD, which
rises to ~3 Å and exhibits much greater fluctuations than for either
of the liganded states.
|
This comparison can be extended by fitting the domain S1 protein
coordinates (saved every 20 ps) on top of the initial structure(s) and
examining the backbone traces of the protein (Fig. 2 B).
From this diagram it is evident that there is a progressive increase in
the motion of domain S2 (relative to domain S1) from Glu1 to Kai to
Apo1. This suggests that the full agonist results in greater immobilization of the domains relative to one another than does the
partial agonist. This is in addition to differences in the degree of
(static) domain closure observed in the x-ray structures (Armstrong and
Gouaux, 2000
).
A further measure of the quality of our simulations is provided by
comparison of temperature (B) factors calculated from simulation root
mean square fluctuations (RMSFs) with those determined experimentally in the x-ray diffraction studies. We found good agreement of the calculated B-factors from the simulation with those reported in the
crystallographic structures. A couple of residues located on the outer
surface loops had values higher than those reported, but generally the
simulated values were consistently lower than the experimental values
by ~5 Å2. Given we observed a significant
difference in inter-domain motion induced by different ligands, we
wished to reassure ourselves that the mean conformation of the protein
in our simulations retained the domain closure seen in the crystal
structures. Therefore, we determined inter-domain distance matrices
averaged over the whole duration of each simulation (Fig.
3). These quite clearly reveal the
gradient in inter-domain contacts between the Apo1 simulation (fewest
contacts) and the Glu1 simulation (most contacts). The mean distances
of these contacts are in accord with the mean degree of domain closure
observed in the crystal structures, indicating that the average
behavior in the MD simulations reproduces the crystallographic
averages. As an additional check we compared the radius of gyration (of
the C
atoms) for each of the simulations to provide a measure of the
overall compactness of the protein. A clear distinction can be seen
between the mean radius of gyration (RGYR) for the three different
simulations with Apo1 (RGYR
19.2 Å) > Kai (RGYR
18.7 Å) > Glu1 (RGYR
18.4 Å).
Furthermore, the fluctuations in the radius of gyration are much
greater for Apo1, again indicative of significant inter-domain motion.
Thus, this analysis supports the conclusion reached by visualization of
the inter-domain motions.
|
Apo2 simulation
We have also performed a simulation (Apo2) starting from the
conformation of the protein observed in the crystal structure with
glutamate bound, but with the ligand removed and replaced by water
molecules (see above). Thus the protein is in the domains-closed state,
but without any stabilizing ligand. This simulation was run for 5 ns.
Even on this timescale we did not see any evidence of net movement of
the domains relative to one another to yield a conformation resembling
that in Apo1. We suspect that much longer simulations (>100 ns) might
be required to see such a conformational change, although domain
motions have on occasions been seen in ~2-ns simulations (Roccatano
et al., 2001
).
We have applied the various analyses described above to the Apo2 simulation. The drift from the initial structure seen in the RMSD plots is similar to that observed for the Glu1 simulation, implying that the protein maintains a conformation that is similar to the glutamate-bound state. The radius of gyration for the Apo2 simulation is ~18.4 Å across the whole 5 ns, which is identical to the value observed for the Glu1 simulation.
Multiple peptide bond conformations
In their analysis of the crystal forms, Armstrong et al. (1998)
observed a flip in the peptide bond between Asp651 and Ser652 for the
AMPA-bound and in one of three glutamate-bound protomers. They
suggested that the switch of this residue from an unflipped to a
flipped conformation was related to receptor activation. Our initial
simulation (Glu1) was based upon protomer A, which in the crystal was
observed in an unflipped conformation. During the 2-ns Glu1 simulation
we did not observe any change in the backbone torsion (
and
)
angles in this region. We investigated this aspect further by running a
simulation (Glu2; see Table 1) starting from protomer C, which has the
flipped conformation of the peptide bond. Within 600 ps, we observed
the
angle of Ser652 to rotate through ~50-60 ° (Fig.
4) and remain in that new conformation for the remainder of the simulation. The new conformation is closer to
the protomer B conformation in the crystal. Thus, our simulations suggest that in the presence of glutamate, multiple conformations of
the Ser652 can exist, as in the x-ray structure. Although it has been
postulated that this flipping could be related to receptor activation
it is very difficult to make any conclusion with respect to the
mechanism for two reasons. The first is the timescale of this
simulation with respect to the timescale of activation; such a
mechanism of activation must involve conformation changes in the region
of the linker, for to observe such a propagation of conformational change would require multiple long simulations. Second,
it could be that the presence of the linker in this region alone infers
different conformation changes than that which occur in the full-length
receptor.
|
The overall RGYR for the Glu2 simulation was 18.4 Å, i.e., identical to that observed for the Glu1 simulation. Our analysis of the RMSD plots also indicated that the overall behavior of the protein in Glu2 was similar to that in the Glu1 simulation.
Binding modes
What is the main distinction between glutamate (a full agonist) and kainate (a partial agonist)? The answer must lie within their manners of binding. We thus examined in detail interactions at the binding sites in the Glu1 and Kai simulations. The binding site is comprised of an intricate network of hydrogen bonds (Fig. 5). It can be seen that the key interactions of domain S1 involving Arg485, Thr480, and Pro478 are seen with both ligands as are the key interactions of domain S2 involving Ser654, Thr655, and Glu705. We have monitored the existence and duration of these key H-bond interactions throughout the Glu1 and Kai simulations (Glu1 and Kai; Fig. 6). Distinct differences are observed between the two ligands in terms of the hydrogen-bond lifetimes.
|
|
For both ligands, Arg485 is observed to maintain the largest number of
contacts for long lifetimes in agreement with the observation (Armstrong and Gouaux, 2000
) that this residue is the primary anchor
for the
-carboxyl group of the ligand and with experiments indicating that mutations of this residue invariably lead to loss of
function (Uchino et al., 1992
; Wafford et al., 1995
; Kawamoto et al.,
1997
). However, there are also some clear differences between the two
ligands. In simulation, Glu1 H-bond analysis revealed two additional
long-lived interactions, not present in the starting structure. These
appeared after 1 ns and were between 1) the NH of Glu and the Thr480
backbone OG atom and 2) the glutamate O and the Arg485 side-chain NH.
This was examined closer and was found to be due to flipping (by
~100°) around the C
-C
bond of the side chain of Thr480 (Fig.
7). The lengths and angles of these H-bonds are summarized in Table 2.
Qualitatively, a change is seen whereby a protein/protein H-bond
(Thr480-Arg485) is replaced by two H-bonds from these side chains to
the ligand, glutamate. It should be noted that a similar flipping of
Thr480 was not seen during the kainate simulation, possibly due to the
presence of the ring in the ligand allowing less flexibility in the
binding site.
|
|
We have analyzed the energetics of these binding modes. The enthalpic energy difference between the two different binding modes for glutamate is not significant. An accurate value for the enthalpic binding energy between glutamate and kainate is not possible from these simulations, but an approximate calculation reveals that the difference is substantial (of the order of 100 kcal/mol).
| |
DISCUSSION |
|---|
|
|
|---|
The main achievements of these simulations have been 1) to reveal a correlation between intra-domain mobility and receptor occupation, such that low mobility corresponds to occupancy by a full agonist, and 2) to show that binding of glutamate to the S1S2 protein may be strengthened beyond that present in the crystal by rotation of the Thr480 side chain. Thus, the simulations may reveal aspects of GluR activation additional to those observed in the x-ray structures.
The principal limitations of the simulations are their relatively short
duration, a result of computational limitations for atomistic
simulations of relatively large systems (~40,000 atoms). This short
duration is problematic with respect to two distinct areas. The first
of these is that the activation event (from ligand binding to channel
opening) is of the order of milliseconds, and it is thus unwise to
extrapolate beyond these current results. The second consideration is
that of statistical sampling. We have performed reasonably long
simulations, but only one flipping event around the Thr480 C
-C
bond is observed for example. Ideally one should run these simulations
many more times to ensure greater confidence that the observed events
are a significant property of the system. One would also like to be
able to estimate how well conformation space has been sampled. We are
quite certain that many more simulations would be needed to start to
address this issue more fully.
Furthermore, even after extending the Apo2 simulation to 5 ns it was
not possible to observe a conformational transition corresponding to
domain opening in the absence of ligand. Comparisons of the different
crystal structures provide clear evidence of domain opening/closure
(Armstrong and Gouaux, 2000
). However, applying similar analyses
(Hingefind (Wriggers and Schulten, 1997
) and DynDom (Hayward and
Berendsen, 1998
)) to any single simulation failed to reveal any
movement of the domains that could be dissected into bilobal hinge
motions. This also suggests that domain closure is on a much longer
timescale than is accessible in current simulations. Indeed, a similar
observation was made for nanosecond simulations of an SH2-SH3 domain
system (Young et al., 2001
), where domain movement was known to exist.
Furthermore, it seems that rare events on this timescale may not be
directly observable, but the collective motions that contribute to
their behavior may well be (Tai et al., 2001
).
The other major limitation, shared with the x-ray studies, is
that our studies are of the water-soluble S1S2 construct rather than
the intact GluR2 protein. However, as shown and discussed in Armstrong
and Gouaux (2000)
, the binding curves for 3H-AMPA
and the IC50 values for ligand displacements are
very similar to longer S1S2 constructs (Chen and Gouaux, 1997
) and to
those for the full-length receptor (Keinänen et al., 1990
). Thus
it seems likely that the pharmacological properties of the S1S2
construct parallel those of the GluR2 receptor per se. Intriguingly,
although very speculative, we also analyzed the movement of the linker residues and surrounding regions. Although the RMSFs of the linker residues were very similar in all three simulations, the RMSF values of
the surrounding residues ~20 residues either side of this linker
region showed noticeably higher values for the apo simulation compared
with the ligand-bound simulations. Remaining residues had
indistinguishable RMSF values. In the full-length protein the linker
region would connect to the transmembrane domain, and it is thus
tempting to try to speculate how this may be related to channel gating,
but this will require much longer simulation times to be able to
investigate this with any confidence.
| |
CONCLUSIONS |
|---|
|
|
|---|
Our main conclusion is that it is important to consider the conformational dynamics of a receptor and to determine how ligand binding may modulate the dynamics. In particular, for the GluR2 it seems that agonist binding not only results in domain closure (as revealed crystallographically) but also results in a decrease in domain mobility (as revealed in simulations) and that the reduction in mobility is greater for a full than for a partial agonist. At a more microscopic level our simulations reveal an important side-chain flipping motion of a residue (Thr480) in the binding site that changes the mode of binding of the agonist (glutamate). This side-chain flip generates an alternative mode of binding not observed for kainate and not observed for glutamate in the crystal structures. Such an observation may have important consequences in the consideration of drug design. However, the timescale of the inter-domain motion is significantly longer than that which is obtainable by conventional MD. We are currently extending this work by using techniques more suited to longer timescales.
| |
ACKNOWLEDGMENTS |
|---|
We thank our colleagues for their interest in this work.
This work was supported by the Wellcome Trust and the Oxford Supercomputer Center.
| |
FOOTNOTES |
|---|
Address reprint requests to Dr. Philip C. Biggin, The University of Oxford, Laboratory of Molecular Biophysics, Department of Biochemistry, The Rex Richards Building, South Parks Road, Oxford OX1 3QU, UK. Tel.: 44-1865-275380; Fax: 44-1865-275182; E-mail: phil{at}biop.ox.ac.uk.
Submitted July 27, 2001, and accepted for publication October 26, 2001.
| |
REFERENCES |
|---|
|
|
|---|
1 subunit.
Brain Res.
47:339-344
-amino-3-hydroxy-5-methyl-4-isoxazol propionic acid receptor subunits is mediated by their N-terminal domains.
J. Biol. Chem.
274:16907-16916
Biophys J, February 2002, p. 676-683, Vol. 82, No. 2
© 2002 by the Biophysical Society 0006-3495/02/02/676/08 $2.00
This article has been cited by other articles:
![]() |
M. L. Blanke and A. M. J. VanDongen Constitutive Activation of the N-Methyl-D-aspartate Receptor via Cleft-spanning Disulfide Bonds J. Biol. Chem., August 1, 2008; 283(31): 21519 - 21529. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Blanke and A. M. J. VanDongen The NR1 M3 Domain Mediates Allosteric Coupling in the N-Methyl-D-aspartate Receptor Mol. Pharmacol., August 1, 2008; 74(2): 454 - 465. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Arinaminpathy, M. S. P. Sansom, and P. C. Biggin Binding Site Flexibility: Molecular Simulation of Partial and Full Agonists within a Glutamate Receptor Mol. Pharmacol., January 1, 2006; 69(1): 11 - 18. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Hansen, R. P. Clausen, E. J. Bjerrum, C. Bechmann, J. R. Greenwood, C. Christensen, J. L. Kristensen, J. Egebjerg, and H. Brauner-Osborne Tweaking Agonist Efficacy at N-Methyl-D-aspartate Receptors by Site-Directed Mutagenesis Mol. Pharmacol., December 1, 2005; 68(6): 1510 - 1523. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Stockner, H. J. Vogel, and D. P. Tieleman A Salt-Bridge Motif Involved in Ligand Binding and Large-Scale Domain Motions of the Maltose-Binding Protein Biophys. J., November 1, 2005; 89(5): 3362 - 3371. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Madden, N. Armstrong, D. Svergun, J. Perez, and P. Vachette Solution X-ray Scattering Evidence for Agonist- and Antagonist-induced Modulation of Cleft Closure in a Glutamate Receptor Ligand-binding Domain J. Biol. Chem., June 24, 2005; 280(25): 23637 - 23642. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Campbell, S. S. Deol, F. M. Ashcroft, I. D. Kerr, and M. S. P. Sansom Nucleotide-Dependent Conformational Changes in HisP: Molecular Dynamics Simulations of an ABC Transporter Nucleotide-Binding Domain Biophys. J., December 1, 2004; 87(6): 3703 - 3715. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Kalbaugh, H. M. A. VanDongen, and A. M. J. VanDongen Ligand-Binding Residues Integrate Affinity and Efficacy in the NMDA Receptor Mol. Pharmacol., August 1, 2004; 66(2): 209 - 219. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Domene, A. Grottesi, and M. S. P. Sansom Filter Flexibility and Distortion in a Bacterial Inward Rectifier K+ Channel: Simulation Studies of KirBac1.1 Biophys. J., July 1, 2004; 87(1): 256 - 267. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. McFEETERS and R. E. OSWALD Emerging structural explanations of ionotropic glutamate receptor function FASEB J, March 1, 2004; 18(3): 428 - 438. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |